How gut bacteria can be an ally in cancer treatment: An emerging paradigm
In a new forum article in the journal Cell Metabolism, Rachel Newsome, Ph.D., and Christian Jobin, Ph.D., highlighted a paradigm shift in the field.
In a new forum article in the journal Cell Metabolism, Rachel Newsome, Ph.D., and Christian Jobin, Ph.D., highlighted a paradigm shift in the field.
The pilot funding was awarded to researchers in all four of the institute's research programs.
Christian Jobin, Ph.D., wrote a column in the Tampa Bay Times on how Gatorade royalties have propelled innovation in his microbiome research.
Christian Jobin, Ph.D., shared his expertise with NPR on how gut bacteria damage may play a role in early-onset colorectal cancer.
Rachel Newsome will present her research on harnessing the gut microbiome to enhance the effectiveness of cancer immunotherapy treatment.
Christian Jobin, Ph.D., is the first distinguished professor in the UF Department of Medicine.
The UF Health Cancer Center has expanded its research programs to strengthen the impact of cancer research and facilitate clinical translation of discoveries.